Glowing rocks in the U.P.? What to know about 'Yooperlites'
Yooperlites are rocks that fluoresce in the dark under ultraviolet light. They became known when a UP resident discovered them in 2017, according to the Michigan Department of Environment, Great Lakes and Energy.
Spring is the best time to search for Yooperlites and other rocks, according to Pure Michigan, because winter ice moved beach sand and stones around, and now has broken up for the season, leaving newly unearthed stones along Lake Superior's shoreline to be discovered.
Throughout the year, the best time to seek Yooperlites and other stones is after a storm, when waves have disrupt and uncover new rocks.
Here's what to know about the rock that is found in the Upper Peninsula along Lake Superior:
Yooperlites are a variety of sodalite-rich syenite found in the Upper Peninsula of Michigan.
Syenite is a coarse-grained, plutonic (intrusive) igneous rock that primarily consists of the minerals feldspar, typically orthoclase feldspar, and often includes smaller amounts of other minerals such as hornblende, mica, or amphibole. Unlike granite, which is another common intrusive igneous rock, syenite contains minimal to no quartz, Geology Science said.
Sodalite is a deep blue to blue-violet mineral best known for its use in jewelry, sculpture, and decorative stonework. Sodalite forms in igneous rocks that crystallized from sodium-rich, silica-poor magmas. That's how it got its name—soda + lithos, or 'sodium stone," according to Rock Your World gem & art gallery.
In normal light, a Yooperlite looks like granite. Sodalite replaces quartz, so the larger the mineral size, the brighter the shine, EGLE said. There are roughly five classes of Yooperlites:
Gemmy (mostly Sodalite or large sodalite crystal, the entire specimen glows orange)
Snowflake or Flower (similar to snowflake obsidian, large blotches on the surface that look like snowflakes, but crystal glow does not penetrate into the interior)
Striated (sodalite fills cracks in the rock matrix, so appears as orange lines or veins)
Spray Paint (tiny crystal droplets scattered around the surface)
Galaxy (larger crystals than spray paint that are dispersed in the rock that glow like the night sky, crystals penetrate the matrix)
The rocks can be found in different areas throughout Michigan, but are most likely to be found in the Upper Peninsula along Lake Superior, often on beaches near Grand Marais and in the Keweenaw Peninsula.
Yooperlites can be found as loose pebbles and cobbles along many Lake Superior beaches and even in some inland gravel pits. The stones are derived from igneous rocks near Marathon, Ontario, known as the Coldwell Alkaline Complex and were transported into Michigan by glaciers during periods of continental glaciation.
How to search for them:
Start with a beach that has known stones
Get a good UV light (365 wavelength)
Wear safety glasses with UV protection
Take along a garden tine rake to move the deposited gravel around or to reach out into the water. Yooperlites may not shine on all surfaces, so moving stones around will increase your chance of seeing them
Be strategic: Use a sweeping side-to-side motion for better coverage and light angle about 6 to 8 feet in front"
Walk at a normal pace and shine the light with a sweeping motion.
According to the EGLE, one person can not exceed 25 pounds per year on state-owned and public trust lands.
These identification techniques, according to the EGLE, can help rock hunters determine the type of rocks they have:
Color (also color of a "streak" if it can be made by swiping the specimen on a piece of porcelain, creating a powder)
Luster (shiny, dull, glassy)
Fluorescence (shines under UV light)
Shape/structure (crystal form or amorphous?)
Breakage (how does it break apart, cleavage or fracture?)
Density/specific gravity (can get an idea by "hefting" to see if it's heavy for its size)
Magnetism
Smell
Radioactivity
The stones can be found across multiple locations in Michigan including:
Eagle River Beach
Whitefish Point
Muskallonge State Park
Grand Marais Beach
Bay Furnace Beach
Pebble Beach
Agate Beach
Misery Bay
Black River Harbor Beach
Agates are formed when gas bubbles in lava leave a hole in the "vesicle" in the rock, according to the Michigan Department of Environment, Great Lakes, and Energy.
Silica (silicon dioxide) solutions flow into the hole in the host rock and fill it up over time, making the bands, the news release says.
Jalen Williams is a trending reporter at the Detroit Free Press. Contact him at jawilliams1@freepress.com.
This article originally appeared on Detroit Free Press: What to know about 'Yooperlites.' How to find Michigan's glowing rocks
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
ANN ARBOR, Mich., August 14, 2025--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three and six months ended June 30, 2025. Business Update Advanced development of TAEUS Liver. ENDRA advanced its product development work with enhancements to the TAEUS Liver system's probe design and proprietary algorithms, which are expected to deliver significantly improved accuracy and repeatability to its liver fat assessments. Initial testing of the new design on a small patient population demonstrated an order-of-magnitude improvement in performance against the gold standard MRI-PDFF measurements. The Company is initiating validation testing of the redesigned probe in a short controlled study to confirm these anticipated performance gains. Focused strategy for TAEUS Liver De Novo submission. The Company further advanced its regulatory strategy regarding its planned De Novo filing for TAEUS Liver with the U.S. Food and Drug Administration (FDA). ENDRA intends to conduct a hypothesis-driven, statistically powered prospective multisite clinical trial enrolling approximately 250 subjects. The final trial design and sample size will be vetted with the FDA, which will assist in achieving the statistical power necessary for the De Novo submission and for publication of results in peer-reviewed journals. The Company expects that the results from the short controlled study will be used for the FDA meetings to confirm the endpoints and protocol. This regulatory alignment is intended to pave the way for the launch of ENDRA's pivotal study by year-end. Expanded the intellectual property portfolio to 85 issued patents globally. During the second quarter of 2025, ENDRA was issued one additional U.S. patent, which covers methods for tuning the thermoacoustic probe. ENDRA's broad intellectual property portfolio provides protection for the TAEUS system with its novel thermoacoustic technology and supports the exploration of licensing opportunities for indications beyond its core focus. Implemented cost reductions while advancing TAEUS development. ENDRA has taken decisive steps to strengthen its financial position over the past nine months. These cost reductions were initiated in the fourth quarter of 2024 and included a decrease in headcount and a streamlining of operations, particularly in general and administrative expenses. As a result, second quarter 2025 operating expenses decreased 42% to $1.2 million compared with $2.2 million in the prior-year period. "Our redesigned TAEUS probe represents a major advancement in our ability to non-invasively assess liver health. The early data are extremely encouraging, and our ongoing validation study is an important step toward aligning with the FDA and beginning our pivotal trial later this year," said Alexander Tokman, ENDRA's Chief Executive Officer. "Metabolic diseases—often symptomless until late stages—are the underlying cause of many chronic illnesses, including steatotic liver disease or SLD, which affects more than two billion people worldwide and over 100 million Americans. Due to the absence of practical diagnostic tools for frontline clinicians, SLD remains grossly underdiagnosed. With TAEUS, we aim to bring liver diagnostics into everyday care and enable earlier detection, better treatment decisions and potentially reduce the enormous financial burden metabolic diseases place on the U.S. healthcare system." Second Quarter Financial Results During 2024, the Company implemented significant cost-reduction initiatives to strengthen its financial position while advancing its strategic priorities. In the second quarter of 2025, the Company's cash burn from operations was $1.1 million, nearly half the $2.1 million reported in the same quarter of 2024. Total operating expenses for the second quarter of 2025 were $1.3 million, down 42% year-over-year from $2.2 million, reflecting the impact of cost-optimization measures including streamlined staffing, reduced overhead and a leaner operating model. As a result, net loss for the second quarter of 2025 narrowed to $1.2 million from $2.2 million in the year-ago period. As of June 30, 2025, ENDRA reported $1.8 million in cash and cash equivalents, providing resources to execute its near-term operational and regulatory milestones. About ENDRA Life Sciences Inc. ENDRA Life Sciences is the pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to assess tissue fat content and monitor tissue ablation during minimally invasive procedures, at the point of patient care. TAEUS® is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. For more information, please visit Forward-Looking Statements All statements in this press release that are not based on historical fact are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of terms such as "approximate," "anticipate," "attempt," "believe," "could," "estimate," "expect," "forecast," "future," "goal," "hope," "intend," "may," "plan," "possible," "potential," "project," "seek," "should," "will," "would," or other comparable terms (including the negative of any of the foregoing), although some forward-looking statements are expressed differently. Examples of forward-looking statements for ENDRA include, among others: expectations with respect to FDA requirements regarding its clinical trials and De Novo submission for its TAEUS liver device; estimates of the timing of future events and anticipated results of its development efforts, including the timing of submission for and receipt of required regulatory approvals and product launches and sales; statements relating to future financial position and projected costs and revenue; expectations concerning ENDRA's business strategy; and statements regarding ENDRA's ability to find and maintain development partners. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements as a result of various factors including, among others: the ability to raise additional capital in order to continue as a going concern; the ability to obtain FDA and other regulatory approvals necessary to sell ENDRA medical devices in certain markets in a timely manner, or at all; the ability to develop a commercially feasible technology and its dependence on third parties to design and manufacture its products; ENDRA's ability to maintain compliance with Nasdaq listing standards and remain listed on a securities exchange; ENDRA's dependence on its senior management team; market acceptance of ENDRA's technology and the amount and nature of competition in its industry; ENDRA's ability to protect its intellectual property; and the other risks and uncertainties described in the Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operations sections of the company's most recent Annual Report on Form 10-K and in subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release speak only as of the date of issuance, and ENDRA assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law. [Financial Tables Follow] ENDRA Life Sciences Inc. Condensed Consolidated Balance Sheets Assets June 30, 2025 December 31, 2024 Current Assets (Unaudited) Cash $ 1,808,574 $ 3,229,480 Prepaid expenses 44,310 204,185 Total Current Assets 1,852,884 3,433,665 Non-Current Assets Fixed assets, net 63,419 69,281 Right of use assets 519,966 578,013 Prepaid expenses, long term 365,417 365,417 Other assets 5,986 5,986 Total Assets $ 2,807,672 $ 4,452,362 Liabilities and Stockholders' Equity Current Liabilities Accounts payable and accrued liabilities $ 448,419 $ 508,293 Lease liabilities, current portion 128,218 96,937 Total Current Liabilities 576,637 605,230 Long Term Debt Lease liabilities 429,274 487,482 Warrant Liability 328,610 799,284 Total Long Term Debt 757,884 1,286,766 Total Liabilities 1,334,521 1,891,996 Stockholders' Equity Series A Convertible Preferred Stock, $0.0001 par value; 10,000 shares authorized; 17,488 and 17,488 shares issued and outstanding, respectively - - Series B Convertible Preferred Stock, $0.0001 par value; 1,000 shares authorized; no shares issued and outstanding - - Series C Preferred Stock, $0.0001 par value; 100,000 shares authorized; no shares issued and outstanding - - Common stock, $0.0001 par value; 20,000,000 shares authorized; 752,390 and 536,908 shares issued and outstanding, respectively 74 53 Additional paid in capital 107,173,418 105,998,412 Stock payable - - Accumulated deficit (105,700,341 ) (103,438,099 ) Total Stockholders' Equity 1,473,151 2,560,366 Total Liabilities and Stockholders' Equity $ 2,807,672 $ 4,452,362 ENDRA Life Sciences Inc. Condensed Consolidated Statement of Operations (Unaudited) Three Months Ended Three Months Ended Six Months Ended Six Months Ended June 30, June 30, June 30, June 30, 2025 2024 2025 2024 Operating Expenses Research and development $ 381,061 $ 716,366 $ 909,746 $ 1,757,892 Sales and marketing 68,834 162,952 137,825 401,612 General and administrative 851,195 1,351,535 1,722,801 2,851,890 Total operating expenses 1,301,090 2,230,853 2,770,372 5,011,394 Operating loss (1,301,090 ) (2,230,853 ) (2,770,372 ) (5,011,394 ) Other Income (Expenses) Other income (expense) 13,066 1,700 37,456 6,541 Warrant expense - - - Changes in fair value of warrant liability 62,112 - 470,674 - Gain or Loss on settlement of warrant exercise - - - Total other expenses 75,178 1,700 508,130 6,541 Loss from operations before income taxes (1,225,912 ) (2,229,153 ) (2,262,242 ) (5,004,853 ) Provision for income taxes - - - - Net Loss $ (1,225,912 ) $ (2,229,153 ) $ (2,262,242 ) $ (5,004,853 ) Net loss per share – basic and diluted $ (1.71 ) $ (0.08 ) $ (3.55 ) $ (0.26 ) Weighted average common shares – basic and diluted 717,107 15,590 637,362 10,857 View source version on Contacts Company Contact: Investor relationsinvestors@ Investor Relations Contact: Yvonne BriggsAlliance Advisors IR(310) 691-7100ybriggs@ 登入存取你的投資組合
New York Times
a day ago
- New York Times
A Surprising (and Easy) Way to Boost Your Attention Span
In 2008, 38 students at the University of Michigan set out on a walk. Half of them wound their way through the trees in Ann Arbor's Nichols Arboretum for 2.8 miles, while the other half navigated the same distance on the busy streets of downtown. A week later, the two groups swapped routes. Both times before they set out, the students took a test that challenged their attention and working memory, where they were given progressively longer sequences of numbers that they had to repeat back in reverse order. When they returned to campus, the students took the test again. Walking through town improved their performance slightly, but walking in nature boosted scores by nearly 20 percent. 'You didn't even need to like or enjoy the nature walk to get these cognitive benefits,' said Marc Berman, a professor of psychology at the University of Chicago, who conducted the study while he was a graduate student at Michigan. People who walked on a cold January day experienced just as much benefit as those who did the experiment in July. The effect that nature has on our minds has been studied many times before and since, and the research generally — though not always — finds that exposure to green spaces boosts our cognition and creativity, not to mention our mood. Many of us have experienced firsthand the natural world's ability to revitalize us — a moment of clarity after summiting a mountain, or renewed focus following a lunchtime stroll in the park. Scientists are trying to understand exactly why that happens. In his new book, 'Nature and the Mind,' Dr. Berman attributes the cognitive benefits of nature to 'attention restoration theory.' First proposed in the 1980s by Rachel and Stephen Kaplan (both of whom were psychology professors at the University of Michigan when Dr. Berman was a student there), the premise is that our ability to focus is a finite resource that gets easily used up, and being in nature is an effective way to replenish it. Want all of The Times? Subscribe.
Yahoo
3 days ago
- Yahoo
First 3D X-ray views of magnesium alloys could revolutionize lightweight car design
A breakthrough in materials science could help engineers design cars that are stronger, lighter, and more fuel-efficient. University of Michigan researchers have used powerful X-rays to capture the first-ever 3D views of microscopic structures inside lightweight magnesium alloys, revealing how they absorb stress without breaking. The discovery opens the door to wider adoption of magnesium in the automotive industry, potentially reducing costs and improving performance Funded by the U.S. Department of Energy, the study offers fresh insight into how magnesium alloys react under mechanical stress. Magnesium is 30% lighter than aluminum, and while some manufacturers already use it for non-load-bearing components, its broader use has been limited by its unpredictable behavior under strain. Understanding and controlling that behavior could make magnesium a mainstream material for vehicle production. Every metal's crystalline structure—the ordered, repeating arrangement of atoms—determines how it responds when pulled or bent. Steel and aluminum have multiple 'slip systems' that let atoms shift easily in any direction, enabling them to stretch without fracturing. Magnesium is more restricted, able to slip atoms in only a few directions. How magnesium handles stress When pulled in directions that do not allow easy slipping, magnesium alloys form 'deformation twins.' These are mirror-image regions in the crystal structure created when atoms in a certain area shift orientation. It is similar to folding a sheet of paper so that one side mirrors the other along the crease. This twinning process increases ductility, allowing the material to stretch in more directions, but excessive twinning can create clusters of defects that eventually cause cracks. In their experiments, the U-M team found that all three types of twins formed at 'triple junctions,' where three crystals meet, and that defects always appeared where the twin touched another crystal. According to Ashley Bucsek, assistant professor of mechanical engineering and materials science, this consistent behavior could be key to optimizing magnesium's lifetime in demanding applications. Before applying stress, the researchers scanned the sample with a small-scale CT machine to map crystal grain orientation. They then selected a grain ideally positioned for tracking the twinning process. X-ray imaging in action To capture the changes in unprecedented detail, the team used the European Synchrotron Radiation Facility in France. Its high-powered X-rays allowed the scientists to image the chosen grain without damaging the sample. They used a technique called dark-field X-ray microscopy, which filters and magnifies X-rays diffracted at specific angles associated with the target grain. The sample was stretched under three different loads—0.6, 30, and 45 megapascals—typical of forces in automotive parts. Between each load, the researchers imaged the grain, effectively watching the twin form and evolve in real space. Lead author Sangwon Lee, a U-M doctoral student, described the experience as 'a front-row seat' to twinning as it happened. These high-resolution images are a first step toward tailoring magnesium alloys to be both more ductile and more stable, bringing them closer to large-scale use in cars and other vehicles. The researchers plan to capture these changes in real time during future experiments. The study appears in the journal Science. Solve the daily Crossword
